TickerFactsScreenerDevelopers

Opus Genetics, Inc. (IRD) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2017: -$15.42M2018: -$18.84M2019: -$3.59M2020: -$6.80M2021: -$19.37M2022: $14.31M2023: -$1.11M2024: -$25.58M2025: -$35.25M-$35.25M
2017Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$35.25M-37.8%
2024-$25.58M-2200.0%
2023-$1.11M-107.8%
2022$14.31M+173.9%
2021-$19.37M-185.0%
2020-$6.80M-89.2%
2019-$3.59M+80.9%
2018-$18.84M-22.2%
2017-$15.42M—